(Q34629286)

3 August 2017

1 reference

title

Lyme neuroborreliosis: infection, immunity, and inflammation (English)

1 reference

3 August 2017

0 references

1 reference

Andrew R Pachner

1

1 reference

PubMed ID

17509489

3 August 2017

Israel Steiner

series ordinal

2

1 reference

3 August 2017

1 June 2007

1 reference

3 August 2017

1 reference

3 August 2017

6

1 reference

3 August 2017

6

1 reference

3 August 2017

544-552

1 reference

Lyme disease-a tick-borne spirochetosis?

3 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970128-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970128-X

1 reference

7 January 2021

Neurologic Abnormalities of Lyme Disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970128-X

7 January 2021

Megabase-sized linear DNA in the bacterium Borrelia burgdorferi, the Lyme disease agent

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970128-X

7 January 2021

Cross-reactivity in serological tests for Lyme disease and other spirochetal infections

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970128-X

7 January 2021

Environmental risk and prevention of Lyme disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970128-X

7 January 2021

Rapid emergence of a focal epidemic of Lyme disease in coastal Massachusetts

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970128-X

7 January 2021

The triad of neurologic manifestations of Lyme disease: meningitis, cranial neuritis, and radiculoneuritis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970128-X

7 January 2021

Serologic analyses of Peromyscus leucopus, a rodent reservoir for Borrelia burgdorferi, in northeastern United States

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970128-X

7 January 2021

Chronic neurologic manifestations of Lyme disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970128-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970128-X

1 reference

7 January 2021

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970128-X

1 reference

7 January 2021

Intrathecal antibody production in a mouse model of Lyme neuroborreliosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970128-X

7 January 2021

Borrelia burgdorferi infection of the brain: characterization of the organism and response to antibiotics and immune sera in the mouse model.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970128-X

7 January 2021

Localization of Borrelia burgdorferi in murine Lyme borreliosis by electron microscopy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970128-X

7 January 2021

Lyme borreliosis in rhesus macaques: effects of corticosteroids on spirochetal load and isotype switching of anti-borrelia burgdorferi antibody

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970128-X

7 January 2021

Localization of Borrelia burgdorferi in the nervous system and other organs in a nonhuman primate model of lyme disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970128-X

7 January 2021

Spinal cord involvement in the nonhuman primate model of Lyme disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970128-X

7 January 2021

Infection and inflammation in skeletal muscle from nonhuman primates infected with different genospecies of the Lyme disease spirochete Borrelia burgdorferi

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970128-X

7 January 2021

Cardiac involvement in non-human primates infected with the Lyme disease spirochete Borrelia burgdorferi

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970128-X

7 January 2021

Comparative analysis of the Borrelia garinii genome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970128-X

7 January 2021

Genotype determines phenotype in experimental Lyme borreliosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970128-X

7 January 2021

Diversity of Ixodes-borne Borrelia species--clinical, pathogenetic, and diagnostic implications and impact on vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970128-X

7 January 2021

Molecular polymorphism of the lyme disease agent Borrelia garinii in northern Europe is influenced by a novel enzootic Borrelia focus in the North Atlantic

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970128-X

7 January 2021

Searching for Lyme disease in Colombia: a preliminary study on the vector

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970128-X

7 January 2021

The polymerase chain reaction in the diagnosis of Lyme neuroborreliosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970128-X

7 January 2021

A rabbit model of Lyme neuroborreliosis: characterization by PCR, serology, and sequencing of the OspA gene from the brain

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970128-X

7 January 2021

Detection of active infection in nonhuman primates with Lyme neuroborreliosis: comparison of PCR, culture, and a bioassay.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970128-X

7 January 2021

Borrelia burgdorferi in the nervous system: the new "great imitator".

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970128-X

7 January 2021

Practice parameters for the diagnosis of patients with nervous system Lyme borreliosis (Lyme disease). Quality Standards Subcommittee of the American Academy of Neurology

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970128-X

7 January 2021

Evidence for Lyme disease in urban park workers: a potential new health hazard for city inhabitants

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970128-X

7 January 2021

A vaccine consisting of recombinant Borrelia burgdorferi outer-surface protein A to prevent Lyme disease. Recombinant Outer-Surface Protein A Lyme Disease Vaccine Study Consortium

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970128-X

7 January 2021

[Erythema migrans borreliosis in the Federal Republic of Germany. Epidemiology and clinical aspects]

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970128-X

7 January 2021

Lyme disease in children in southeastern Connecticut. Pediatric Lyme Disease Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970128-X

7 January 2021

Chronische lymphocytäre Meningitis, entzündliche Polyneuritis und „Rheumatismus”

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970128-X

7 January 2021

Meningopolyradiculitis (Bannwarth syndrome) as primary manifestation of a centrocytic-centroblastic lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970128-X

7 January 2021

Comparison of findings for patients with Borrelia garinii and Borrelia afzelii isolated from cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970128-X

7 January 2021

Lymphocytic meningoradiculitis in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970128-X

7 January 2021

Lyme neuroborreliosis. Peripheral nervous system manifestations

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970128-X

7 January 2021

Early disseminated Lyme disease: Lyme meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970128-X

7 January 2021

Antibody Response in Lyme Disease: Evaluation of Diagnostic Tests

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970128-X

7 January 2021

Intrathecal immune response in patients with neuroborreliosis: specificity of antibodies for neuronal proteins

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970128-X

7 January 2021

The clinical and epidemiological profile of Lyme neuroborreliosis in Denmark 1985-1990. A prospective study of 187 patients with Borrelia burgdorferi specific intrathecal antibody production

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970128-X

7 January 2021

Relevance of cerebrospinal fluid variables for early diagnosis of neuroborreliosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970128-X

7 January 2021

Clinical manifestations and diagnosis of neuroborreliosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970128-X

7 January 2021

Lyme neuroborreliosis: central nervous system manifestations

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970128-X

7 January 2021

Evaluation of the intrathecal antibody response to Borrelia burgdorferi as a diagnostic test for Lyme neuroborreliosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970128-X

7 January 2021

Western blotting in the serodiagnosis of Lyme disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970128-X

7 January 2021

Antibody responses to the three genomic groups of Borrelia burgdorferi in European Lyme borreliosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970128-X

7 January 2021

An improved recombinant IgG immunoblot for serodiagnosis of Lyme borreliosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970128-X

7 January 2021

Diagnosis of Lyme neuroborreliosis with antibodies to recombinant proteins DbpA, BBK32, and OspC, and VlsE IR6 peptide

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970128-X

7 January 2021

Diagnosis of lyme borreliosis in europe

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970128-X

7 January 2021

Significance of reactive Lyme serology in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970128-X

7 January 2021

FLAIR and magnetization transfer imaging of patients with post-treatment Lyme disease syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970128-X

7 January 2021

Simultaneous involvement of third and sixth cranial nerve in a patient with Lyme disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970128-X

7 January 2021

Multiple sclerosis and positive Lyme serology

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970128-X

7 January 2021

Chronic fatigue syndrome in patients with Lyme borreliosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970128-X

7 January 2021

"Chronic Lyme disease" as the incorrect diagnosis in patients with fibromyalgia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970128-X

7 January 2021

Lyme Disease Associated with Fibromyalgia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970128-X

7 January 2021

Lyme borreliosis-associated encephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970128-X

7 January 2021

Memory impairment and depression in patients with Lyme encephalopathy: Comparison with fibromyalgia and nonpsychotically depressed patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970128-X

7 January 2021

Lyme encephalopathy: a neuropsychological perspective

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970128-X

7 January 2021

Lyme encephalopathy: long-term neuropsychological deficits years after acute neuroborreliosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970128-X

7 January 2021

Neurologic manifestations in children with North American Lyme disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970128-X

7 January 2021

Ceftriaxone Compared with Doxycycline for the Treatment of Acute Disseminated Lyme Disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970128-X

7 January 2021

Neurologic abnormalities of Lyme disease: successful treatment with high-dose intravenous penicillin

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970128-X

7 January 2021

Clinical pharmacokinetics of ceftriaxone

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970128-X

7 January 2021

Ceftriaxone as effective therapy in refractory Lyme disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970128-X

7 January 2021

Practice guidelines for the treatment of Lyme disease. The Infectious Diseases Society of America

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970128-X

7 January 2021

Comparison of intravenous penicillin G and oral doxycycline for treatment of Lyme neuroborreliosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970128-X

7 January 2021

Successful Oral Doxycycline Treatment of Lyme Disease‐Associated Facial Palsy and Meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970128-X

7 January 2021

5-y Follow-up Study of Patients with Neuroborreliosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970128-X

7 January 2021

Chronic symptoms are common in patients with neuroborreliosis -- a questionnaire follow-up study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970128-X

7 January 2021

Treating post Lyme disease: trying to solve one equation with too many unknowns

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970128-X

7 January 2021

Detection of attenuated, noninfectious spirochetes in Borrelia burgdorferi-infected mice after antibiotic treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970128-X

7 January 2021

Two Controlled Trials of Antibiotic Treatment in Patients with Persistent Symptoms and a History of Lyme Disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970128-X

7 January 2021

Dermal inflammation elicited by synthetic analogs of Treponema pallidum and Borrelia burgdorferi lipoproteins.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970128-X

7 January 2021

Increased expression of B-lymphocyte chemoattractant, but not pro-inflammatory cytokines, in muscle tissue in rhesus chronic Lyme borreliosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970128-X

7 January 2021

The nervous system as ectopic germinal center: CXCL13 and IgG in lyme neuroborreliosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970128-X

7 January 2021

The chemokine CXCL13 (BLC): a putative diagnostic marker for neuroborreliosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970128-X

7 January 2021

Cytokine CXCL13--a possible early CSF marker for neuroborreliosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970128-X

7 January 2021

Sublime diagnosis of Lyme neuroborreliosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970128-X

7 January 2021

Role of immunoglobulin G in killing of Borrelia burgdorferi by the classical complement pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970128-X

7 January 2021

Differential binding of host complement inhibitor factor H by Borrelia burgdorferi Erp surface proteins: a possible mechanism underlying the expansive host range of Lyme disease spirochetes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970128-X

7 January 2021

Serum-resistant strains of Borrelia burgdorferi evade complement-mediated killing by expressing a CD59-like complement inhibitory molecule

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970128-X

7 January 2021

Early and early disseminated phases of Lyme disease in the rhesus monkey: a model for infection in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970128-X

7 January 2021

Inoculation of nonhuman primates with the N40 strain of Borrelia burgdorferi leads to a model of Lyme neuroborreliosis faithful to the human disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970128-X

7 January 2021

Expression of complement factor H binding immunoevasion proteins in Borrelia garinii isolated from patients with neuroborreliosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970128-X

7 January 2021

Serodiagnosis of Lyme disease by kinetic enzyme-linked immunosorbent assay using recombinant VlsE1 or peptide antigens of Borrelia burgdorferi compared with 2-tiered testing using whole-cell lysates

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970128-X

7 January 2021

Comparison of Western immunoblotting and the C6 Lyme antibody test for laboratory detection of Lyme disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970128-X

7 January 2021

Variable antigen genes of the relapsing fever agent Borrelia hermsii are activated by promoter addition

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970128-X

7 January 2021

Antigenic variation in Lyme disease borreliae by promiscuous recombination of VMP-like sequence cassettes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970128-X

7 January 2021

Conservation and heterogeneity of vlsE among human and tick isolates of Borrelia burgdorferi.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970128-X

7 January 2021

10.1016/S1474-4422(07)70128-X

Identifiers

DOI

1 reference

3 August 2017

1 reference

PubMed ID

17509489